Loading…
CIK 0001910456 • 7 13F filings • May 15, 2025 – Aug 13, 2026
Import this data to Google Sheets with:
=jivedata("lynx1-capital-management-lp","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| ALLOGENE THERAPEUTICS INC | COM | $12.5M | 3.6% | 11,057,009 SH | New |
| ASSEMBLY BIOSCIENCES INC | COM NEW | $188K | 0.1% | 10,366 SH | New |
| C4 THERAPEUTICS INC | COM STK | $10.2M | 2.9%Prev: 2.9% | 7,098,133 SH | Decreased+99,231 SH |
| CULLINAN THERAPEUTICS INC | COM | $33.1M | 9.6%Prev: 20.1% | 4,400,842 SH | Decreased-4,562,658 SH |
| DESIGN THERAPEUTICS INC | COM | $222K | 0.1%Prev: 0.2% | 65,954 SH | Decreased-53,562 SH |
| GH RESEARCH PLC | ORDINARY SHARES | $82.2M | 23.8%Prev: 23.9% | 6,746,951 SH | Decreased-4,016,337 SH |
| IBIO INC | COM NEW | $1.2M | 0.3%Prev: 0.0% | 1,538,573 SH | Increased+1,470,497 SH |
| MERUS N V | COM | $82.5M | 23.8% | 1,568,841 SH | New |
| NEUPHORIA THERAPEUTICS INC | COM | $325K | 0.1%Prev: 0.6% | 45,806 SH | Decreased-829,522 SH |
| PASSAGE BIO INC | COM | $3.7M | 1.1% | 9,256,953 SH | New |
| PRECISION BIOSCIENCES INC | COM NEW | $4.4M | 1.3%Prev: 0.9% | 1,036,051 SH | Decreased+50,938 SH |
| PROTAGONIST THERAPEUTICS INC | COM | $40.5M | 11.7% | 733,014 SH | New |
| STOKE THERAPEUTICS INC | COM | $61.3M | 17.7%Prev: 24.5% | 5,404,674 SH | Decreased+641,001 SH |
| TSCAN THERAPEUTICS INC | COM | $11.4M | 3.3%Prev: 1.3% | 7,857,347 SH | Increased-161,801 SH |
| UPSTREAM BIO INC | COM | $2.4M | 0.7% | 219,247 SH | New |
| 13F-HR/A |
| 0001910456-26-000004 |
| $865.5M |
| View |
| Aug 14, 2025 | Q2 2025 | 13F-HR | 0001085146-25-005127 | $346.2M | View |
| May 4, 2026 | Q1 2026 | 13F-HR | 0001910456-26-000002 | $632.7M | View |
| May 15, 2025 | Q1 2025 | 13F-HR | 0001892688-25-000120 | $279.2M | View |